In a statement to Bursa Malaysia addressing the group ' s recent trading activities , the group emphasised its commitment to executing its strategic plan for business growth .

TDM ' s share price reached a three-year high on Apr 4 , closing 14 per cent higher at 32.5 sen , amid growing market valuation ascribed to its healthcare-related businesses . This surge follows the RM5.7 billion divestment of Ramsay Sime Darby Health Care Sdn Bhd ( RSDH ) to Columbia Asia Healthcare Sdn Bhd .

The group added that it is not privy to any undisclosed corporate developments concerning the group ' s operations or affairs that could explain the recent trading activity .

A report by The Edge on Mar 25 highlighted the RSDH-Columbia Asia transaction , setting a valuation precedent for private hospital

KL Wellness City ( KLWC ), Southeast Asia ' s first purpose-built township , has launched its flagship tertiary hospital , KL International Hospital Sdn Bhd ( KLIH ).

The first phase of KLIH is anticipated to reach a development worth of RM1 billion , targeting completion by the second quarter of 2026 with its doors expected to open in the third quarter of the same year .

KLIH is set to be a 624-bed tertiary hospital , expandable to accommodate 1,000 beds , furnished with cutting-edge amenities to furnish a holistic healthcare service ecosystem that synergizes with KLWC ’ s overarching healthcare and wellness framework .

During the inauguration event , Health Minister Datuk Seri Dr Dzulkefly Ahmad said : " This visionary development augurs well and complements the Government ' s vision and effort to be the world ' s leading medical and healthcare one-stop centre .

“ I ’ m pleased to see a strong commitment in investing and leveraging on information and communications technology ( ICT ) within the hospital , in its quest to be equipped with the first and best medical innovation including robotics in Malaysia .”

The Health Ministry expressed gratitude for KLIH ' s RM2 million pledge to aid B40 individuals seeking medical assistance .

“ This generous contribution enhances our efforts to provide accessible healthcare to underprivileged communities , reinforcing our shared commitment to health equity in Malaysia .”

KLWC Managing Director Dato ' Dr Colin Lee said : “ As we launch the KLIH within the KLWC , we ' re constructing not just a stateof-the-art facility but infusing it with a cutting-edge healthcare ecosystem .

“ This development represents our commitment to enhancing the standard of living through integrated wellness and healthcare , operators in Malaysia and attracting investor attention to players like TDM .

The report also outlined TDM ' s Vision 2027 strategic plan , targeting a post-tax profit of RM32 million with a four per cent margin and aiming for an expanded bed capacity of 880 across its hospitals . By 2027 , the plan envisions serving 84,028 inpatients and 652,740 outpatients .

TDM , majority owned by the Terengganu government via Terengganu Inc Sdn Bhd with a 60 per cent stake , operates five hospitals in strategic locations across Malaysia , including Taman Desa and Kelana Jaya in the Klang Valley , Kuantan and Kuala Terengganu on the peninsula ' s east coast , and Tawau in Sabah .

From left : Ministry of Health Malaysia Medical Development Division Director Dato ' Dr Mohd Azman Yacob , KL Wellness City Managing Dire�t�r Dat�� Dr ���in �ee� Hea�th �inister Datuk �eri Dr D�u�ke�� Ahmad , and Ministry of Health Malaysia Medical Practice Division Deputy Director Dr Mimi Zalwani Zakaria .

setting a new benchmark for medical excellence in Malaysia as well as Southeast Asia ”.

Strategically nestled in Bukit Jalil , Kuala Lumpur , KLIH boasts 22 operating theaters , including provisions for robotic and hybrid surgeries . The hospital ' s diverse medical services , spanning from complex surgeries to tertiary and secondary care , aim to attract top-tier medical talent and leverage Artificial Intelligence ( AI ) to streamline patient wait times .

KLIH is also pursuing Green Building Index certification , underlining its dedication to sustainable development alongside its global healthcare services .

THE FEDERAL Court has granted the Government and the Ministry of Health ( MoH ) permission to appeal against a Court of Appeal decision that permitted doctors to prescribe Ivermectin to patients .

The three-judge panel , led by Court of Appeal president Abang Iskandar Abang Hashim , stated that the application held merit due to its implications for public health .

" We , therefore , permit all six legal questions to be further discussed in the appeal process ," said Abang Iskandar , alongside Chief Judge of Sabah and Sarawak Abdul Rahman Sebli and Justice Hanipah Farikullah .

The online proceedings saw senior federal counsel Rahazlan Affandi Abdul Rahim and Liew Horng Bin representing the health ministry and Government , while lawyers Gurdial Singh Nijar and Abraham Au represented the doctors .

The Government asked whether legitimising the use and dispensation of Ivermectin by registered medical professionals defied the principles of justice , considering the lack of assurance regarding its safety for human use or efficacy in treating Covid-19 .

On Aug 25 , 2023 , the Court of Appeal ruled that registered medical practitioners could prescribe Ivermectin to patients , subject to compliance with Section 19 of the Poisons Act 1952 and the Poison Regulations 1952 .

The Court of Appeal clarified that the ruling did not promote Ivermectin as an alternative Covid-19 treatment but recognised medical practitioners ' discretion in prescribing Group B Poisons , including Ivermectin , to their patients .

The appeal stemmed from a lawsuit filed by two doctors , namely Dr S Vijaendran , who is Chairman of the Malaysian Association for the Advancement of Functional and Interdisciplinary Medicine and Dr Che Amir Farid Che Isahak , against the Health Ministry and the Government on Sept 21 , 2021 .

They sought clarity on whether registered medical practitioners could prescribe Ivermectin to patients under the Poisons Act 1952 and the Poison Regulations 1952 .

On June 14 , 2021 , officers from the Selangor health department ' s pharmaceutical services division confiscated Ivermectin from Dr Amir ' s clinic .